Skip to main content

Comparing Immune-Humanized Mouse Platforms for Preclinical Applications

Published Date

The highly immunodeficient NSG™ platform enables precise in vivo modeling of human immune responses. This platform offers researchers a powerful tool for characterizing and validating immune-modulating therapeutics. During this presentation, we will compare strategies for immune humanization of NSG variants to support translatable preclinical immunology, and oncology research.

Join us to learn about:

  • HSC and PBMC immune cell humanization techniques using the NSG platform
  • The impact of host selection and genetic modifications (e.g., growth factors and cytokines) on engrafted immune phenotypes
  • Novel NSG variants that offer improved human innate immune cell development